Analysis Digital Health Drug Development 
Healthcare IT News - Telehealth
MAY 29, 2020
Contactless monitoring systems and smartphone health applications are playing a vital role in the war against COVID-19, a report has found. Telemedicine has experienced a huge surge in adoption over the past few months, during the coronavirus pandemic, according to Aline Noizet , founder of Digital Health Connector.
Digital Health Global
JANUARY 28, 2025
a leading provider of clinical development technology, today announced new data from the Tufts Center for the Study of Drug Development (CSDD)s PACT Consortium links decentralized clinical trial (DCT) approaches to notably higher participation rates across multiple demographic groups. PALO ALTO, Calif.–(BUSINESS
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lloyd Price
NOVEMBER 16, 2024
Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today! Subscribe Today!
Digital Health Global
JANUARY 10, 2024
Key Highlights of the Partnership: 1) Expanding Indications : The partnership will harness TNL’s AI Digital Cells Lab platform to explore additional indications for one of Debiopharm’s cancer drugs. Debiopharm’s main activities include drug development, drug manufacturing and digital health investment.
Lloyd Price
OCTOBER 14, 2024
Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today! Regulatory Landscape: Changes in healthcare regulations and policies.
Digital Health Global
APRIL 5, 2024
Furthermore, the industry witnessed a decline in the average return on investment (ROI) for R&D to as low as 1.2%, and the peak sales per asset valued just above $350 million, indicating a need to build more efficient drug development processes with the implementation of newer technologies.
Digital Health Global
JANUARY 29, 2025
a leading provider of clinical development technology, today announced new data from the Tufts Center for the Study of Drug Development (CSDD)s PACT Consortium linking decentralized clinical trial (DCT) approaches to notably higher proportional representation among select demographic subgroups. Medable Inc., versus 0.5%).
Expert insights. Personalized for you.
180 
Let's personalize your content